|Cardax Inc -- USA Stock|| |
USD 0.17 0.01 6.25%
Mr. Richard M. Morris is Secretary of the Cardax, Inc. Mr. Morris has served as Assistant Secretary of Pharma since May 2013 and Assistant Secretary of Holdings since July 2013. Mr. Morris is a Partner at Herrick, Feinstein LLP, our legal counsel . As a partner of Herrick, Mr. Morris represents a variety of clients, primarily in corporate matters. Prior to becoming a lawyer, Mr. Morris was an auditor with the Commodities Exchange in New York and later focused on operations and financial management at Kidder Peabody. He also was the U.S. Audit Manager for the financial division for a diversified Australian company
Age: 54 Executive Since 2014
Morris has a B.S. in Accounting from New York University and a J.D. from Fordham University School of Law, with bar admissions in New York and Connecticut.
The company has return on total asset (ROA)
of (43.62) %
which means that it has lost $43.62 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (12.0) %
meaning that it created substantial loss on money invested by shareholders.
Cardax, Inc., a life sciences company, focuses on developing consumer health and pharmaceutical technologies for solutions that would provide the antiinflammatory benefits of steroids or nonsteroidal antiinflammatory drugs. Cardax Inc (CDXI) is traded on OTC Market in USA. It is located in HAWAII, U.S.A and employs 9 people. Cardax is listed under Restaurants Hotels Motels category by Fama And French industry classification.